Label: SENEXON-S- docusate sodium -sennosides tablet, coated

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated December 30, 2013

If you are a consumer or patient please visit this version.

View All Sections
  • ACTIVE INGREDIENT

    Active ingredients (in each tablet)

    Docusate sodium 50 mg

    Sennosides 8.6 mg

  • ASK DOCTOR

    ASK A DOCTOR BEFORE USE IF YOU HAVE A SUDDEN CHANGE IN BOWEL HABITS THAT LASTS OVER TWO WEEKS

  • ASK DOCTOR/PHARMACIST

    Ask a doctor or pharmacist berfore use if you are taking any other drug.  Laxatives may affect how other drugs work.

  • WARNINGS

    Do not use if your are taking mineral oil; for longer than one week; when abdominal pain, nausea or vomiting are present

  • KEEP OUT OF REACH OF CHILDREN

    Keep out of reach of children.  In case of overdose, get medical help or contact a Poison Control Center right away.

  • PREGNANCY OR BREAST FEEDING

    If pregnant or breast-feeding, ask a health professional before use.

  • PURPOSE

    Uses:  relieves occasional constipation; generally produces bowel movement in  6-12 hours.

  • QUESTIONS

    call 1 800 645-2158 9 am - 5 pm Monday - Friday

  • STOP USE

    Stop use and ask a doctor if: you have rectal bleeding; you fail to have a bowel movement after use of this product.  These may indicate a serious condition.

  • INACTIVE INGREDIENT

      Inactive ingredients

    carnauba wax, colloidal silicon dioxide, croscarmellose sodium

    D-C yellow #10 aluminum lake, dibasic calcium phosphate

    dihydrate, FD-C yellow #6 aluminum lake, hypromellose,

    magnesium stearate, microcrystalline cellulose, polyethylene

    glycol, sodium benzoate, stearic acide, Titanium dioxide

  • WHEN USING

    Directions take preferably at bedtime or as directed by a doctor

    If you do not have a comfortable bowel movement by the second day, increase dose by one tablet (do not exceed maxiumum dosage)




  • DOSAGE & ADMINISTRATION


    Dosage and Administration

    Adults and children 12 years and over - 2 tablets once a day - maximum dosage - 4 tablets twice a day

    children 6 to under 12 years - 1 tablet once a day maximum dosage - 2 tablets twice a day

    children 2 to under 6 years - 1/2 tablet once a day - maximum dosage- 1 tablet twice a day

    children uner 2 years - ask a doctor

  • INDICATIONS & USAGE

    RELIEVES OCCASIONAL CONSTIPATION

    GENERALLY PRODUCES BOWEL MOVEMENT IN 6-12 HOURS

  • PRINCIPAL DISPLAY PANEL

    Repackaged By :
    Aidarex Pharmaceuticals LLC,
    Corona, CA 92880

    IMAGE LABEL
  • INGREDIENTS AND APPEARANCE
    SENEXON-S 
    docusate sodium -sennosides tablet, coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:33261-749(NDC:0536-4086)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) DOCUSATE SODIUM50 mg
    SENNOSIDES A AND B (UNII: 1B5FPI42EN) (SENNOSIDES A AND B - UNII:1B5FPI42EN) SENNOSIDES A AND B8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    CARNAUBA WAX (UNII: R12CBM0EIZ)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    D&C YELLOW NO. 10 (UNII: 35SW5USQ3G)  
    CALCIUM PHOSPHATE, DIBASIC, DIHYDRATE (UNII: O7TSZ97GEP)  
    FD&C YELLOW NO. 6 (UNII: H77VEI93A8)  
    HYPROMELLOSE 2910 (6 MPA.S) (UNII: 0WZ8WG20P6)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    POLYETHYLENE GLYCOLS (UNII: 3WJQ0SDW1A)  
    SODIUM BENZOATE (UNII: OJ245FE5EU)  
    STEARIC ACID (UNII: 4ELV7Z65AP)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Product Characteristics
    ColorORANGEScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code TCL081
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:33261-749-00100 in 1 BOTTLE, PLASTIC
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC MONOGRAPH NOT FINALpart33403/16/2011
    Labeler - Aidarex Pharmaceuticals LLC (801503249)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!